Skip Navigation
< Back
QualityTool

Guideline Recommendations for HER2 Testing in Breast Cancer: Summary Slide Set


Description

This slideshow presentation summarizes the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer.

This slideshow contains 25 slides and is organized into the following sections:

  • Introduction
  • Guideline methodology
  • Background
  • Guideline questions
  • Optimal testing algorithm for the assessment of HER2 status
  • Optimal performance, interpretation, and reporting
  • Additional ASCO/CAP resources
Links to the Tool:
This tool is available at: http://www.asco.org/sites/default/files/her2_slides_5.28.08.pdf (If you don't have the software to open this PDF, download free Adobe Acrobat Reader® software External Web Site Policy.)

Developer

American Society of Clinical Oncology; College of American Pathologists

Funding Sources

American Society of Clinical Oncology; College of American Pathologists


QualityTool Topic

Disease/Condition-Related; Guideline-Related


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse: Guideline Recommendations for HER2 Testing in Breast Cancer: Summary Slide Set:
http://www.guideline.gov/summary/summary.aspx?doc_id=10384

History

  • Release Date: 12/2006
  • Original Summary: 06/2007
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification

Disease/Clinical Category:
Patient Population:
IOM Domains of Quality:
QualityTool Format:

Last updated: April 10, 2013.